Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$1.2B
Avg Funding
$47.7M
Cities
24

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Brisbane, Australia
$3.5M
raised

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Mölndal, Sweden
$564K
raised

Pioneering advanced cancer diagnostics and regenerative medicine treatments.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Charlottesville, United States
$32.0M
raised

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Richmond Hill, Canada
$2.1M
raised

Cheelcare develops robotic mobility devices and accessories for people with disabilities.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Salem, United States
$140.0M
raised

Prokidney provide specialized treatment for chronic kidney disease.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Heidelberg, Germany
$50.0M
raised

VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oslo, Norway
$31.5M
raised

Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$10.5M
raised

CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miami Beach, United States
$13.8M
raised

AirSculpt Technologies is a provider of body contouring procedures delivering under its brand, Elite Body Sculpture.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Lexington, United States
$2.5M
raised

iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Zug, Switzerland
$132.3M
raised

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$25.0M
raised

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Perth, Australia
$1.5M
raised

InteliCare has commercialized a predictive analytics engine hardware and software system for use in the aged care and health industries.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hong Kong, Hong Kong

Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Bethesda, United States
$100.0M
raised

Chiron Real Estate selectivity acquires leading healthcare providers' core real estate assets nationwide.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Paris, France
$45.0M
raised

Abivax develops medicines that alter the body's natural immune system mechanisms.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$735K
raised

Vanta Holdings develops beverage and nutraceutical products focused on longevity, hydration, and human performance.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States
$7.0M
raised

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Göteborg, Sweden
$11.0M
raised

IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Tucson, United States
$5.0M
raised

Picard Medical brings to the table technical and commercial expertise.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$150.0M
raised

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$276.0M
raised

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$74.2M
raised

Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.

May 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$2.0M
raised

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked